Astellas Pharma Inc. (ALPMF)
OTC: ALPMF
· Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Aug 08, 2025, 2:03 PM
Astellas Pharma Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 74.9B | -97.66B | 35.91B | 37.6B | -33.28B | 21.45B | 5.33B | 46.85B | -47.88B | 59.76B | 88.8B | 31.68B | -10.52B | 78.32B | 53.26B | 35.83B | -18.9B | 75.14B | 28.85B | 60.24B |
Depreciation & Amortization | 47.68B | 51.16B | 50.02B | 50.27B | 48.64B | 46.98B | 38.97B | 23.24B | 23.02B | 23B | 22.85B | 36.87B | 21.08B | 21.52B | 18.94B | 18.14B | 18.56B | 18.15B | 17.94B | 18B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | 14.47B | 23.08B | 18.28B | 14.55B | 20.97B | -18.99B | 64.46B | 27.84B | -13.77B | 19.67B | -11.23B | 9.92B | 4.37B | -33.15B | 24.4B | -20.87B | 10.51B | -43.45B |
Other Non-Cash Items | 961M | 134.68B | -1.24B | -49.27B | 130.14B | 9.15B | 15.41B | -16.35B | 113.03B | 7.97B | -17.61B | 10.48B | 32.75B | -37.67B | 8.83B | 11.01B | 58.43B | 36.36B | 35.8B | -9.99B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -22.46B | -72.16B | -19.87B | -26B | 22.31B | -26.17B | -22.83B | -41.55B | 27.42B | -18.41B | -3.02B | -30.2B | 5.27B | 7.31B | 18.28B | -24.9B | 23.61B | -19.46B | 10.77B | -46.65B |
Operating Cash Flow | 101.08B | 16.03B | 64.81B | 12.6B | 74.55B | 51.41B | 36.88B | 12.2B | 115.59B | 72.32B | 91.03B | 48.83B | 48.59B | 69.47B | 99.3B | 40.08B | 81.7B | 110.18B | 93.36B | 21.6B |
Capital Expenditures | -9.7B | 2.29B | -15.6B | -14B | -19.92B | -15.27B | -30.94B | -16.36B | -28.12B | -20.73B | -21.43B | -18.26B | -17.27B | -11.3B | -27.96B | -19.91B | -18.58B | -15.82B | -9.78B | -33.26B |
Cash Acquisitions | n/a | n/a | n/a | n/a | -190M | -24.73B | -760.05B | n/a | n/a | n/a | n/a | n/a | -11M | -10M | -1M | -648M | -13M | -13.2B | -40M | -1.67B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 456M | 64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 6.73B | -33.02B | -782M | -25.35B | -4.62B | -309M | 19.96B | 4.06B | 4.94B | -6.45B | 5.91B | -885M | 2.46B | 10.91B | -26.52B | -525M | 4.43B | -433M | -136M | 6.6B |
Investing Cash Flow | -2.96B | -30.72B | -16.38B | -39.35B | -24.73B | -40.31B | -771.03B | -12.3B | -22.72B | -27.12B | -15.52B | -19.14B | -14.83B | 8.16B | -34.66B | -21.09B | -14.16B | -29.45B | -9.96B | -28.33B |
Debt Repayment | -23.55B | -15.57B | -16.49B | -9.55B | 43.12B | 1.13B | n/a | n/a | -50B | n/a | n/a | 15B | -20B | n/a | n/a | n/a | -45B | -19B | -32B | -30B |
Common Stock Repurchased | -1M | -1M | -1M | -6.96B | -1M | -2M | -1M | -10.73B | -50B | -2M | n/a | -10.55B | -50B | -1M | -2M | -713M | -8.28B | -1M | -1M | -880M |
Dividend Paid | n/a | -66.23B | n/a | -62.76B | n/a | -62.75B | n/a | -53.9B | n/a | -54.68B | n/a | -45.68B | n/a | -46.32B | n/a | -38.91B | n/a | -39.01B | n/a | -37.15B |
Other Financial Acitivies | -67.26B | -22.49B | -37.85B | 67.34B | -12.19B | -25.4B | 505.12B | 229.68B | -4.5B | 44.99B | -34.83B | -5.37B | -5.03B | -5B | -45.2B | -5.1B | -4.86B | -3.59B | -4.76B | -4.95B |
Financial Cash Flow | -90.81B | -104.3B | -54.34B | -11.92B | 30.93B | -87.03B | 505.12B | 165.04B | -104.5B | -9.69B | -34.83B | -46.6B | -75.03B | -51.33B | -45.21B | -44.73B | -58.14B | -61.6B | -36.76B | -72.98B |
Net Cash Flow | 8.51B | 179.87B | -302.93B | 302.93B | 81.71B | -80.02B | -227.49B | 184.65B | -4.98B | 20.74B | 48.06B | -2.97B | -34.23B | 31.92B | 16.38B | -24.21B | 19.61B | 19.78B | 46.8B | -78.46B |
Free Cash Flow | 91.38B | 18.32B | 49.21B | -1.4B | 54.63B | 36.14B | 5.94B | -4.17B | 87.47B | 51.58B | 69.59B | 30.57B | 31.31B | 58.17B | 71.34B | 20.17B | 63.12B | 94.36B | 83.58B | -11.66B |